Today

Agents

Chat

Arena

Discover

More

App

AstraZeneca's Breztri Now Available in US for Asthma Patients 12+ - AZN News | Rallies

AstraZeneca's Breztri Now Available in US for Asthma Patients 12+

AZN•2026-07-20

Breztri now available in the US for asthma patients 12+

July 20 (Reuters) - AstraZeneca PLC AZN.L:

AstraZeneca: Breztri is now available in US as first and only fixed-dose triple therapy for asthma patients 12 years of age and older

Further company coverage: AZN.L

Related News

Alexander's Inc <ALX.N>: Piper Sandler Raises Target Price to $212 From $190

ALX•2026-07-21

Domino's Pizza Inc <DPZ.O>: RBC raises target price to $350 from $325

DPZ•2026-07-21

New Zealand gas exploration interest picks up after years in doldrums

•

2026-07-20

Goldman sees Brent exceeding $120/bbl in Q4 if Hormuz disruptions persist

GS•2026-07-21

PJT Partners updates financial calendar for upcoming earnings release, conference call

PJT•2026-07-20